Amgen receives US FDA approval for Uplizna to treat Adults with generalized myasthenia gravis: Thousand Oaks, California Saturday, December 13, 2025, 11:00 Hrs [IST] Amgen announc ...

Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...

It’s an open-ended index fund replicating the Nasdaq 100 Index. With attractive returns clocked by this index attracting ...

Shane Lowry opened up about his fitness in a recent interview. The Irish golfer is enjoying some time away from the greens ...

RTE Late Late Show viewers were left gushing after a Toy Show favourite returned to the studio just a week after stealing the nation’s hearts. The youngster became an instant fan favourite ...

Quick Read Schwab US Dividend Equity ETF (SCHD) has lagged tech funds during the AI boom due to minimal exposure to growth ...

The US regulator has approved a new use for Amgen’s blockbuster bone drug Xgeva, to prevent fractures in patients with newly-diagnosed multiple myeloma with bone metastases. Xgeva (denosumab) has ...

Discover a diversified portfolio of ETFs & CEFs for 6%+ income yield, market-matching growth, and lower tech risk.